- Home
- PNR vs ICLR Comparison
PNR vs ICLR Comparison
Compare PNR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNR | ICLR |
|---|---|---|
| Founded | 1966 | 1990 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.3B |
| IPO Year | 2003 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PNR | ICLR |
|---|---|---|
| Price | $65.68 | $165.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $109.73 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 3.3M | 775.2K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.34% | N/A |
| EPS Growth | ★ 5.88 | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.24 | N/A |
| Revenue Next Year | $4.82 | N/A |
| P/E Ratio | $62.97 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.60 | $66.57 |
| 52 Week High | $113.95 | $203.91 |
Technical Indicators
Market Signals| Indicator | PNR | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 49.29 |
| Support Level | $57.60 | $157.06 |
| Resistance Level | $77.03 | $193.08 |
| Average True Range (ATR) | 2.68 | 7.55 |
| MACD | 0.23 | -1.37 |
| Stochastic Oscillator | 40.78 | 11.95 |
Price Performance
Historical ComparisonAbout PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.